Research and Development

The Research and Development team at Oblique Therapeutics focuses on creating innovative antibody-based medications for chronic pain and metastatic cancer. Comprising experts in medicinal chemistry, clinical pain, and preclinical research, the team collaborates to advance drug candidates from early-stage research through preclinical development, ensuring the efficacy and safety of new therapeutic approaches.